 |
인쇄하기
취소
|
Anterogen files stem-cell related patent
Anterogen Co., an affiliated company of Bukwang Pharm, says it has filed a patent application for adipose-derived stem cells to treat bowel or fecal incontinence.
The patent is characterized by a cellular composition mixing two adipose-derived stem cells by regenerating malfunctioned sphincter tissues.
Bowel or fecal incontinence is the loss of voluntary control of stool, or bowel movemen...
The patent is characterized by a cellular composition mixing two adipose-derived stem cells by regenerating malfunctioned sphincter tissues.
Bowel or fecal incontinence is the loss of voluntary control of stool, or bowel movemen...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.